Nick Lee Email & Phone Number

Marlborough, MA, US

Hologic, Inc. (Nasdaq: HOLX, S&P 500, ~$17B Market Cap, ~7k Employees) is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women's health.- Lead a team of 7 to deliver BSH (Breast and Skeletal Health) product management, application, and servicing effort to clients in China.

California, 94086, US

• Intuitive Fosun is a JV formed by Intuitive Surgical and Fosun Pharma.
• Lead a 6-member team in overseeing upstream and downstream product marketing activities for the Da Vinci ecosystem, with a focus on new product launches, localization efforts, and competitive intelligence
• Launch 2 advanced instruments (Vessel Sealer Extend and SureForm 45/60). Positioned for extended live instruments and domestic platform for portfolio expansion strategy and policy alignment initiatives
• Execute and strategize various market related projects: end-of-life product transition, potential domestic new product development, VBP impact, and tender shaping

Miami Lakes, FL, US

• Spearhead a variety of deal activities including in-licensing and JV to enrich endovascular product portfolio offerings to Greater China region by exploring >10 partnerships and expanded 1 existing partnership
• Developed and executed APAC corporate goals, collaborating with regional and global stakeholders to achieve immediate outcomes and meet company targets

Forchheim, DE

• (Corindus Vascular Robotics acquired by Siemens Healthineer for $1.1bn in Oct.2019)
• Led upstream product development initiatives in collaboration with the R&D team to expand indications into the neuro-vascular field and ensure compatibility with the next-gen remote robotic platform
• Conducted comprehensive market intelligence and engaged key opinion leaders (KOLs) to align product development goals with real-world practices and device partners across 3 vascular beds
• Monitored market intelligence and technical advancements of more than 15 robotic surgical stakeholders to inform product strategy, competitive landscape analysis, and potential deal activities
• Assisted in the NMPA (China FDA) regulatory process and expert meetings to facilitate regulatory approval in China and other clinical pilot initiatives.

Forchheim, DE

• Led $50mn strategic JV partnerships (China-focused roadshow, term sheet, due diligence) with 4 potential strategic alliances and >10 investors to expand innovative interventional robotic technology into new markets
• Developed and executed robust market forecasts, business intelligence, and financial modeling to support high-level strategic partnership decision-makingNYSE: CVRS

Boston, Massachusetts, US

• BHA serves multi-national medtech / life science companies on strategical and tactical engagements involving portfolio management, market access, and business development exercises. Selected client experience as below:
• Partnered with multinational pharmaceutical and MedTech companies on strategic and tactical projects involving portfolio management, market access, due diligence, and business development
• Conducted comprehensive market research and product portfolio assessments for a global imaging manufacturer, optimizing market and product segmentation
• Identified and prioritized procedures and associated medical technologies to be added to a major international provider network within orthopedic, spine, and cardiac service lines

Durham, NC, US

Certificate: Healthcare Sector Management

Paris, France, FR

• Built an ROI model reflecting the return of past marketing investments and served as future budget planning tool in rare disease department

Meyrin, CH

• Analyzed and prioritized market access opportunities for 7 EMEA countries where Labatec aims to achieve 46% CAGR in the next five years

New Taipei, TW

• Led digital health platform strategy to increase international sales volume and accounts
• Increased new international customer accounts through multiple engagements. Accounted for $10MM in annual sales with projected YoY growth of +10%
• Reengaged inactive accounts through “solution selling”, e.g. providing new TeleHealth systems, serving as an invaluable business resource and providing value-added services to clients

• Managed global client accounts and successfully boosted company’s presence in several overseas markets, accounting for $2MM in annual sales
• Relayed feedback from clients to research & development team and achieved 20% increase in customer satisfaction
• Launched the first Myo-Electrical Hand (BeBionic) into Greater China market

Master Of Business Administration (Mba), Strategy | Healthcare Sector Management

Bachelor Of Science, School Of Biomedical Science And Engineering

Credit Courses, Human Medicine